Abstract
Diabetes is associated with increased risk of target lesion failure after percutaneous coronary intervention. In this substudy of the SORT OUT VII ([NCT01879358][1]) trial we compared the clinical outcome among patient with and without diabetes mellitus treated with sirolimus-eluting stent (O-SES,
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
